RJFSA
TARS icon

Raymond James Financial Services Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$341K Sell
10,362
-2,664
-20% -$74.9K ﹤0.01% 2886
2024
Q2 		$354K Sell
13,026
-37,924
-74% -$1.28M ﹤0.01% 2772
2024
Q1 		$1.85M Buy
50,950
+7,131
+16% +$210K ﹤0.01% 1675
2023
Q4 		$887K Buy
43,819
+13,162
+43% +$220K ﹤0.01% 2057
2023
Q3 		$545K Buy
30,657
+13,801
+82% +$244K ﹤0.01% 2271
2023
Q2 		$305K Buy
+16,856
New +$268K ﹤0.01% 2657

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Raymond James Financial Services Advisors's TARS Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Tarsus Pharmaceuticals (TARS) stake by 20% in Q3 2024, selling an estimated $74.9K and leaving 10,362 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Raymond James Financial Services Advisors first reported a position in TARS in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.85M in Q1 2024. 162 funds tracked by Wall St. Rank hold TARS as of Q3 2024.

  • Raymond James Financial Services Advisors held 10,362 shares of Tarsus Pharmaceuticals worth $341K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 2,664 Tarsus Pharmaceuticals shares in Q3 2024, an estimated $74.9K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2886 holding.
  • Raymond James Financial Services Advisors first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • Raymond James Financial Services Advisors's Tarsus Pharmaceuticals position peaked at $1.85M in Q1 2024.
  • 162 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.